News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Press Releases
Browse the the latest press releases from around the industry. Want to filter press releases by date, keyword, and more? Search
here.
THE LATEST
Press Releases
Restart Life Receives Aggregate Gross Proceeds of Approximately $590,000 from Warrant Exercises and Loan
December 22, 2025
·
5 min read
Press Releases
Entheon Announces Letter of Intent with Nutravisor Inc.
December 22, 2025
·
7 min read
Press Releases
Restart Life Sciences Signs Binding LOI to Acquire The Holy Crap Foods Portfolio of Brands and Manufacturing Plant
December 22, 2025
·
9 min read
Press Releases
GenSight Biologics Announces the Granting of Compassionate Use Authorization (CUA/AAC) for GS010/LUMEVOQ® in France
December 22, 2025
·
2 min read
Press Releases
FDA Approves Genentech’s Lunsumio VELO™ for Subcutaneous Use in Relapsed or Refractory Follicular Lymphoma
December 22, 2025
·
16 min read
Press Releases
Mondego Bio Announces Selection of a PTPN2 Inhibitor Clinical Candidate and Targets First-in-Human Trials in H1 2026
December 22, 2025
·
3 min read
Press Releases
Faron Announces Strategic Collaboration with The Institute for Cancer Research to Launch BLAZE Trial, Targeting Immunotherapy Resistance in Cancer
December 22, 2025
·
5 min read
Press Releases
Alvotech announces European launch of first-in-market biosimilar to Simponi® (golimumab) globally by partner Advanz Pharma
December 22, 2025
·
4 min read
Press Releases
Nomination Committee Appointed for AGM 2026 in Ascelia Pharma AB
December 22, 2025
·
2 min read
Press Releases
FDA approves Roche’s Lunsumio VELO™ for subcutaneous use in relapsed or refractory follicular lymphoma
December 22, 2025
·
8 min read
Press Releases
Ipsen expands early development pipeline with Simcere Zaiming’s innovative antibody drug conjugate
December 22, 2025
·
7 min read
Press Releases
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - December 19, 2025
December 22, 2025
·
2 min read
Press Releases
Bristol Myers Squibb Announces Agreement with U.S. Government to Improve Affordability and Access to Critical Medicines for Americans
December 22, 2025
·
10 min read
Press Releases
Windward Bio Expands Immunology Pipeline With WIN027, a Long-Acting, Clinical-Stage Bispecific Targeting TSLP and IL-13
December 22, 2025
·
4 min read
Press Releases
Samsung Biologics Expands U.S. Manufacturing Capabilities with Strategic Acquisition of Human Genome Sciences from GSK
December 22, 2025
·
4 min read
Press Releases
Precision Medicine Portfolio Update: Illuccix China Phase 3 Study, TLX101-CDx and TLX250-CDx FDA Resubmissions
December 22, 2025
·
11 min read
Press Releases
T-MAXIMUM Pharmaceutical’s Allogeneic CAR-T Therapy MT027 Receives FDA IND Clearance to Proceed to Phase II clinical Trial for Recurrent Glioblastoma
December 22, 2025
·
4 min read
Press Releases
Merck Reaches Agreement With U.S. Government to Expand Access to Medicines and Lower Costs for Americans
December 22, 2025
·
6 min read
Press Releases
Aptose Biosciences Announces Rescheduling of Special Meeting of Shareholders to Approve the Acquisition by Hanmi Pending Final Clearance from SEC
December 22, 2025
·
6 min read
Press Releases
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - December 19, 2025
December 22, 2025
·
3 min read
Press Releases
Genentech Announces Agreement With U.S. Government
December 22, 2025
·
2 min read
Press Releases
Gilead and U.S. Government Enter Agreement to Lower Costs of Medicines for Americans
December 22, 2025
·
5 min read
Press Releases
Medtronic announces filing of IPO registration statement for Diabetes business, MiniMed
December 22, 2025
·
5 min read
Press Releases
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - December 19, 2025
December 22, 2025
·
1 min read
Press Releases
Nxera Pharma to Regain Full Rights to GPR52 Agonist Program for Schizophrenia
December 19, 2025
·
5 min read
Press Releases
Acadia Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026
December 19, 2025
·
1 min read
Press Releases
Arcus Biosciences to Participate in the 44th Annual J.P. Morgan Healthcare Conference
December 19, 2025
·
1 min read
Press Releases
Rezubio Announces $20 Million Series A Financing to Advance the Membrane-Anchored Therapeutics Platform and Company Pipeline, with Lead Program in Obesity and Diabetes
December 19, 2025
·
1 min read
Press Releases
Mesa Labs to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026
December 19, 2025
·
1 min read
Press Releases
Syneron Bio Closes Nearly $100M in Series A and A+ Rounds
December 19, 2025
·
1 min read
Press Releases
Kodiak Sciences Announces Closing of $184 Million Public Offering of Common Stock including Full Exercise of Underwriters’ Option to Purchase Additional Shares
December 19, 2025
·
3 min read
Press Releases
NEW DRUG APPLICATION FOR TINENGOTINIB TABLETS ACCEPTED BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION
December 19, 2025
·
2 min read
Press Releases
Meiji Seika Pharma Partners With MBC BioLabs to Strengthen Global Innovation in Drug Discovery
December 19, 2025
·
2 min read
Press Releases
Revolutionary Single-Track Process Transforms Nonclinical Data Management
Xbiom™ Platform Introduces AI-Enabled Automated Workflow that Eliminates Redundant Processes, Reduces Costs by 50%, and Accelerates IND-Enabling Regulatory Submission Readiness by 2-4 Weeks
December 18, 2025
·
1 min read